MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc Logo
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 375 GBX Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

257.9m
-4%
Assets
Growth Rates:
1 Year
-8%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
31.6m
-13%
Liabilities
Growth Rates:
1 Year
-6%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
226.4m
-3%
Equity
Growth Rates:
1 Year
-9%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
MaxCyte Inc

257.9m
Assets
31.6m
Liabilities
257.9m
Assets
31.6m
Liabilities
Current Assets 178.7m
Cash & Short-Term Investments 157.5m
Receivables 6m
Other Current Assets 15.2m
Non-Current Assets 79.3m
Long-Term Investments 45m
PP&E 33.9m
Other Non-Current Assets 295k
Current Liabilities 13.5m
Accounts Payable 1.7m
Accrued Liabilities 7.3m
Other Current Liabilities 4.5m
Non-Current Liabilities 18.1m
Other Non-Current Liabilities 18.1m

Balance Sheet
MaxCyte Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3
2
12
25
11
15
19
48
11
47
Cash Equivalents
3
2
12
25
11
15
19
48
11
47
Short-Term Investments
0
0
0
0
3
2
16
207
216
122
Total Receivables
1
2
2
3
5
3
5
7
14
6
Accounts Receivables
1
2
2
3
5
3
5
7
14
6
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1
1
1
1
2
4
4
5
9
12
Other Current Assets
0
1
0
1
1
1
1
3
3
4
Total Current Assets
6
6
16
31
23
25
45
270
252
190
PP&E Net
0
0
0
1
2
6
7
13
34
35
PP&E Gross
0
0
0
1
2
6
7
13
34
35
Accumulated Depreciation
1
1
1
1
2
2
3
4
6
10
Long-Term Investments
0
0
0
0
0
0
0
0
0
43
Other Long-Term Assets
0
0
0
0
0
0
0
0
1
0
Total Assets
6
N/A
6
+2%
16
+152%
31
+95%
24
-23%
30
+23%
52
+73%
284
+448%
287
+1%
268
-6%
Liabilities
Accounts Payable
1
2
3
4
4
2
1
2
1
1
Accrued Liabilities
0
0
0
0
0
4
6
7
8
12
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
1
0
0
0
0
0
0
0
0
Other Current Liabilities
1
2
3
2
2
3
5
7
7
5
Total Current Liabilities
4
5
6
6
7
9
12
16
15
18
Long-Term Debt
4
4
5
5
5
5
5
0
0
0
Other Liabilities
0
0
0
0
0
2
2
6
17
18
Total Liabilities
8
N/A
10
+20%
11
+16%
12
+7%
12
+2%
16
+37%
19
+13%
21
+14%
33
+54%
36
+10%
Equity
Common Stock
44
45
0
1
1
1
1
1
1
1
Retained Earnings
45
48
52
62
71
83
95
114
138
176
Additional Paid In Capital
0
0
56
81
82
96
128
376
391
407
Total Equity
2
N/A
3
-94%
5
N/A
20
+284%
12
-37%
14
+11%
33
+144%
263
+692%
254
-3%
232
-9%
Total Liabilities & Equity
6
N/A
6
+2%
16
+152%
31
+95%
24
-23%
30
+23%
52
+73%
284
+448%
287
+1%
268
-6%
Shares Outstanding
Common Shares Outstanding
44
44
44
51
51
57
77
101
102
104

See Also

Summary
MXCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
MXCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MXCT stock valuation using valuation multiples.
Wall Street Estimates
MXCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MXCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.